secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001104659-25-051292
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth extends mandatory conversion period for Series C preferred stock from 15 to 24 months
--------------------------------------------------------------------------------

- Mandatory conversion period extended from 15 to 24 months for Series C, C-1, C-2 preferred stock.
- Preferred holders will receive a quarterly dividend of 15% of common shares issuable upon conversion.
- No new securities were issued or sold as a result of the amendment.
- Amended and restated certificates of designation filed on May 20, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465925051292/0001104659-25-051292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465925051292/tm2515738d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-051292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer